Wells Fargo & Company Genocea Biosciences, Inc. Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.01 - $1.38 $164 - $22,718	-16,463 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.96 - $1.35 $6,720 - $9,451	7,001 Added 73.99%	16,463 $20,000
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.99 $195 - $409	-206 Reduced 2.13%	9,462 $11,000
Q3 2021 Nov 15, 2021	BUY	$1.74 - $2.33 $236 - $316	136 Added 1.43%	9,668 $18,000
Q2 2021 Aug 16, 2021	BUY	$2.06 - $2.82 $4 - $5	2 Added 0.02%	9,532 $22,000
Q1 2021 May 13, 2021	BUY	$2.35 - $4.01 $7 - $12	3 Added 0.03%	9,530 $26,000
Q4 2020 Feb 09, 2021	BUY	$1.91 - $2.67 $15 - $21	8 Added 0.08%	9,527 $23,000
Q3 2020 Nov 05, 2020	SELL	$1.81 - $5.53 $1,413 - $4,318	-781 Reduced 7.58%	9,519 $22,000
Q2 2020 Aug 13, 2020	SELL	$1.66 - $3.06 $11,975 - $22,074	-7,214 Reduced 41.19%	10,300 $23,000
Q1 2020 May 14, 2020	BUY	$1.26 - $2.73 $22,067 - $47,813	17,514 New	17,514 $30,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.